SSRIs for mild cognitive impairment to Alzheimer’s disease
Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment?
An estimated 10% of people...
Millions of Australians at risk of heart disease
Data from the Australian Bureau of Statistics (ABS) suggests that 13 million people have at least three risk factors for developing cardiovascular disease (CVD).1 A...
Post-partum president
Chelsea Felkai MPS usually balances a busy life of university teaching, PhD study and community pharmacy locum shifts in Newcastle, NSW.
Future health series: pharmacy can adjust the sails
It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series.
Most...
How psilocybin can help terminally ill patients
Psilocybin, a psychoactive compound found in ‘magic mushrooms’, is being trialled in the treatment of terminally ill patients to reduce symptoms of depression and...
COVID-19 rollout strategy recalibrated
Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.
